Literature DB >> 34150037

Plasma cytokine changes and its clinical significance in intracranial infection secondary to traumatic brain injury.

Nannan Zhang1, Zhibo Zhang1, Hongxiao Wang1, Dan Liu1, Yingying Deng1.   

Abstract

OBJECTIVE: This study aimed to investigate the plasma cytokine changes and its clinical significance in intracranial infection secondary to traumatic brain injury.
METHODS: A total of 60 cases with intracranial infection secondary to traumatic brain injury admitted to our hospital from January 2017 to December 2019 were selected as the research objects, of whom, 24 cases with mild infection, 20 with moderate infection, and 16 with severe infection. Another 60 cases without intracranial infection secondary to traumatic brain injury during the same period were selected as the uninfected group. A comparison of infected and uninfected groups on changes of plasma cytokines (IL-1β, IL-2, IL-6, IL-8, TNF-α, IFN-γ) and high mobility group-1 protein (HMGB1) were conducted to analyze the correlation between plasma cytokines and disease severity.
RESULTS: The data of IL-1β, IL-2, IL-6, IL-8, TNF-α, IFN-γ and HMGB1 levels in both groups on day 1, day 3 and day 5 after the surgery were obtained. The results indicated that for infected group, the differences were significant among these 3 days (P<0.05), and the data on day 5 were all higher than that on day 1 and day 3 (P<0.05). While for uninfected group, there was no significant difference among those 3 days (P>0.05). The differences in different severity of infection on day 5 showed statistically significance (P<0.05), and it was positively correlated with the severity (P<0.05).
CONCLUSION: The cytokines content in intracranial infection secondary to traumatic brain injury increased significantly, which was closely related to the severity of the infection. These factors can be used as monitoring indicators for diagnosis of intracranial infection and assessment ofthe severity. AJTR
Copyright © 2021.

Entities:  

Keywords:  HMGB1; IFN-γ; Intracranial infection secondary to traumatic brain injury; TNF-α; interleukin

Year:  2021        PMID: 34150037      PMCID: PMC8205820     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  21 in total

Review 1.  T-cell subsets (Th1 versus Th2).

Authors:  S Romagnani
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

2.  Analysis on the risk factors of intracranial infection secondary to traumatic brain injury.

Authors:  Chao Lin; Xin Zhao; Haichen Sun
Journal:  Chin J Traumatol       Date:  2015

Review 3.  Trauma, head injury, and neurosurgery infections.

Authors:  M C Boque; M Bodi; J Rello
Journal:  Semin Respir Infect       Date:  2000-12

Review 4.  Interleukin-8, a chemotactic and inflammatory cytokine.

Authors:  M Baggiolini; I Clark-Lewis
Journal:  FEBS Lett       Date:  1992-07-27       Impact factor: 4.124

Review 5.  The pro- and anti-inflammatory properties of the cytokine interleukin-6.

Authors:  Jürgen Scheller; Athena Chalaris; Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Biochim Biophys Acta       Date:  2011-02-04

6.  High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage.

Authors:  Takashi Nakahara; Ryosuke Tsuruta; Tadashi Kaneko; Susumu Yamashita; Motoki Fujita; Shunji Kasaoka; Teruto Hashiguchi; Michiyasu Suzuki; Ikuro Maruyama; Tsuyoshi Maekawa
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

7.  Systemic and local high mobility group box 1 concentrations during severe infection.

Authors:  Marieke A D van Zoelen; Pierre-François Laterre; Suzanne Q van Veen; Jan W O van Till; Xavier Wittebole; Paul Bresser; Michael W Tanck; Thierry Dugernier; Akitoshi Ishizaka; Marja A Boermeester; Tom van der Poll
Journal:  Crit Care Med       Date:  2007-12       Impact factor: 7.598

Review 8.  Extracellular HMGB1 as a proinflammatory cytokine.

Authors:  Guoqian Chen; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  J Interferon Cytokine Res       Date:  2004-06       Impact factor: 2.607

9.  Distinct interferon signatures stratify inflammatory and dysimmune myopathies.

Authors:  Muriel Rigolet; Cyrielle Hou; Yasmine Baba Amer; Jessie Aouizerate; Baptiste Periou; Romain K Gherardi; Peggy Lafuste; François Jérôme Authier
Journal:  RMD Open       Date:  2019-02-26

10.  Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury.

Authors:  Qiang Zhang; Hongxing Chen; Chao Zhu; Fangzhou Chen; Suohui Sun; Nan Liang; Wei Zheng
Journal:  Exp Ther Med       Date:  2019-04-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.